| Tracy Beth Head, PHARMD, CGP | |
|
643 S. Main Street, Deforest, WI 53532 | |
| (608) 846-2750 | |
| (608) 846-2751 |
| Full Name | Tracy Beth Head |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 643 S. Main Street, Deforest, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043429707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14709-040 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tracy Beth Head, PHARMD, CGP 643 S. Main Street, Deforest, WI 53532 Ph: (608) 846-2750 | Tracy Beth Head, PHARMD, CGP 643 S. Main Street, Deforest, WI 53532 Ph: (608) 846-2750 |
News Archive
Human adult stem cells injected around the damage caused by a heart attack survived in the heart and improved its pumping efficiency for a year in a mouse model, researchers at The University of Texas MD Anderson Cancer Center report online ahead of publication in Circulation Research.
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
A recent study by French researchers has demonstrated that experimental exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) is capable of inducing mild infection in hamsters and ferrets within 7 – 10 days of exposure. However, the infection completely resolves within 14 days. The study is currently available on the bioRxiv preprint server.
ALDA Pharmaceuticals Corp. announces that it has entered into a Supplier Agreement with Acklands-Grainger Inc.("AGI"). ALDA's products will be distributed through AGI's five distribution centres to its 160 branches across Canada and included in AGI's full catalogue of products. Dr. Terrance Owen, President & CEO states, "This agreement with AGI is an important step in achieving nation-wide distribution of our products.
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
› Verified 2 days ago
Mr. Birpaul Bhander, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 645 S Main St, Deforest, WI 53532 Phone: 608-846-4736 Fax: 608-846-6892 | |
Mr. Daniel R Knuteson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4502 Oak Springs Cir, Deforest, WI 53532 Phone: 608-846-4899 |